The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.
about
Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseasesMelanocortin peptides: potential targets in systemic lupus erythematosusBacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infectionBoth MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in miceNeural regulation of innate immunity: a coordinated nonspecific host response to pathogens.Alpha-melanocyte stimulating hormone (α-MSH) is a post-caspase suppressor of apoptosis in RAW 264.7 macrophages.Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophagesThe Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human KeratinocytesGastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling.Tuning inflammation with anti-inflammatory neuropeptides.The neuropeptides α-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells.Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection.Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditionsRetinal Pigment Epithelial Cells Suppress Phagolysosome Activation in Macrophages.Applications of the role of α-MSH in ocular immune privilege.IRAK-M regulation and function in host defense and immune homeostasis.The alpha-melanocyte stimulating hormone induces conversion of effector T cells into treg cellsNeuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative DiseasesThe diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
P2860
Q26849739-6444D850-7360-4DE3-AA04-B60CC2AC5917Q26865343-A6838B97-1C0E-4AF2-BB00-CEE44C08B8F9Q26998053-91946695-239C-43AB-84B0-5A3729C0B432Q28298659-3745AD7A-C479-401D-80DD-B94EDC751883Q34504753-9394883E-70A8-48B1-B524-976C1B1FCA92Q34979873-AB256B35-01C7-45CA-9D68-5B4395965860Q35227663-A17ED43E-9824-4C85-8CEB-FE5D93832B78Q35756125-44F0DD27-76E4-4D21-810D-3BDF1606D730Q36434344-3B91880A-967D-402A-BA6A-5E8AB7916FCDQ36764912-F12EAD16-34F3-495B-95B2-3A911B0C43A9Q36920147-1507495B-C25C-48B4-8163-E8DBCE60E44AQ36971794-6E26694F-4F86-44C1-B1F2-8187CB28065AQ37191369-E943E453-9E0D-453B-BFDD-A0FBE626118EQ37328069-4F3A509E-0417-4B00-90BE-7CF4F43E05D2Q37492012-A3859EC7-F604-4F88-A8B2-DC5431575459Q37686701-7A7EBAEA-F076-42BD-B67D-881B08CDDF9EQ37827463-B6EFD062-B9A3-4487-BA5D-A458C7D48283Q37851354-0F4C33E2-21DF-4417-A16D-C5BD6E73DEE7Q38501748-6F3418FE-E355-4EE3-BF70-A306D942E2AEQ39116758-A031EE91-187E-4707-9F1F-B61D04E812CBQ41975249-9B58A09B-B6A1-4706-A34C-677D8169764F
P2860
The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The immunomodulating neuropept ...... R4 with IRAK-M in macrophages.
@ast
The immunomodulating neuropept ...... R4 with IRAK-M in macrophages.
@en
type
label
The immunomodulating neuropept ...... R4 with IRAK-M in macrophages.
@ast
The immunomodulating neuropept ...... R4 with IRAK-M in macrophages.
@en
prefLabel
The immunomodulating neuropept ...... R4 with IRAK-M in macrophages.
@ast
The immunomodulating neuropept ...... R4 with IRAK-M in macrophages.
@en
P2860
P1476
The immunomodulating neuropept ...... LR4 with IRAK-M in macrophages
@en
P2093
A W Taylor
P2860
P356
10.1016/J.JNEUROIM.2005.01.008
P50
P577
2005-05-01T00:00:00Z